Phosphoinositide 3 Kinase Inhibitor Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
CRIS | F | Curis, Inc. | 10.81 | |
APTO | F | Aptose Biosciences, Inc. | -10.66 | |
APLM | F | Apollomics Inc. | -32.58 | |
PRLD | F | Prelude Therapeutics Incorporated | 0.57 |
Related Industries: Biotechnology
Related Stock Lists:
Cancer
Biopharmaceutical
Solid Tumors
Acute Myeloid Leukemia
Clinical Medicine
Drugs
Lymphoma
Medicine
Non Small Cell Lung Cancer
Oncology
Protein Kinase Inhibitor
Small Molecule Therapies
Targeted Therapy
Advanced Non Small Cell Lung Cancer
Antineoplastic Drugs
Bacterial Infections
Bemcentinib
Blastoma
Breast Cancer
Cancer Cell
Related ETFs - A few ETFs which own one or more of the above listed Phosphoinositide 3 Kinase Inhibitor stocks.
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
CNCR | F | Loncar Cancer Immunotherapy ETF | 0.55 | |
IWC | B | iShares Microcap ETF | 0.01 | |
HDG | A | ProShares Hedge Replication ETF | 0.0 | |
ITWO | B | ProShares Russell 2000 High Income ETF | 0.0 | |
IWM | B | iShares Russell 2000 ETF | 0.0 |
Compare ETFs
Related Industries:
Biotechnology
Related Stock Lists:
Cancer
Biopharmaceutical
Solid Tumors
Acute Myeloid Leukemia
Clinical Medicine
Drugs
Lymphoma
Medicine
Non Small Cell Lung Cancer
Oncology
Protein Kinase Inhibitor
Small Molecule Therapies
Targeted Therapy
Advanced Non Small Cell Lung Cancer
Antineoplastic Drugs
Bacterial Infections
Bemcentinib
Blastoma
Breast Cancer
Cancer Cell
- Phosphoinositide 3 Kinase Inhibitor
Phosphoinositide 3-kinase (PI3K) inhibitors are drugs that block the activity of the PI3K enzyme, which is involved in many cellular processes, including cell growth, proliferation, and survival. PI3K inhibitors are used to treat certain types of cancer, as they can help to slow or stop the growth of cancer cells.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles